4 minute read
Aug. 26, 2022
Compound 3f: an Oral Factor XIa (FXIa) Inhibitor for Thromboembolic Diseases
compound 3f
oral Factor XIa inhibitor IV efficacy in rabbit AV shunt model from literature starting point and SBDD J. Med. Chem., July 21, 2022 Janssen Research & Development, L.L.C., Spring House, PA